HPC
IRMD icon

HM Payson & Co’s iRadimed IRMD Stock Holding History

HM Payson & Co’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
2,718
+7
+0.3% +$638 ﹤0.01% 407
2026
Q1 		$261K Buy
2,711
+18
+0.7% +$1.8K ﹤0.01% 389
2025
Q4 		$262K Buy
2,693
+23
+0.9% +$1.97K ﹤0.01% 377
2025
Q3 		$190K Buy
2,670
+34
+1% +$2.27K ﹤0.01% 441
2025
Q2 		$158K Buy
2,636
+16
+0.6% +$877 ﹤0.01% 457
2025
Q1 		$137K Buy
2,620
+17
+0.7% +$955 ﹤0.01% 476
2024
Q4 		$143K Buy
2,603
+18
+0.7% +$947 ﹤0.01% 476
2024
Q3 		$130K Buy
2,585
+15
+0.6% +$692 ﹤0.01% 486
2024
Q2 		$113K Buy
2,570
+45
+2% +$1.91K ﹤0.01% 483
2024
Q1 		$111K Buy
2,525
+19
+0.8% +$840 ﹤0.01% 491
2023
Q4 		$119K Hold
2,506
– – ﹤0.01% 471
2023
Q3 		$111K Hold
2,506
– – ﹤0.01% 467
2023
Q2 		$120K Buy
2,506
+30
+1% +$1.35K ﹤0.01% 447
2023
Q1 		$97.4K Buy
2,476
+12
+0.5% +$436 ﹤0.01% 476
2022
Q4 		$69.7K Hold
2,464
– – ﹤0.01% 515
2022
Q3 		$74K Hold
2,464
– – ﹤0.01% 514
2022
Q2 		$84K Hold
2,464
– – ﹤0.01% 496
2022
Q1 		$110K Sell
2,464
-1,992
-45% -$92.1K ﹤0.01% 478
2021
Q4 		$206K Buy
4,456
+16
+0.4% +$645 ﹤0.01% 399
2021
Q3 		$149K Buy
4,440
+7
+0.2% +$238 ﹤0.01% 428
2021
Q2 		$130K Buy
4,433
+28
+0.6% +$772 ﹤0.01% 440
2021
Q1 		$114K Buy
4,405
+45
+1% +$1.07K ﹤0.01% 464
2020
Q4 		$99K Hold
4,360
– – ﹤0.01% 476
2020
Q3 		$93K Hold
4,360
– – ﹤0.01% 459
2020
Q2 		$101K Hold
4,360
– – ﹤0.01% 429
2020
Q1 		$93K Hold
4,360
– – ﹤0.01% 413
2019
Q4 		$102K Hold
4,360
– – ﹤0.01% 466
2019
Q3 		$92K Hold
4,360
– – ﹤0.01% 486
2019
Q2 		$89K Buy
+4,360
New +$103K ﹤0.01% 508

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HM Payson & Co's IRMD Position: Q2 2026 in Review

HM Payson & Co increased its iRadimed (IRMD) stake by 0.26% in Q2 2026, buying an estimated $638 and bringing the position to 2,718 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

HM Payson & Co first reported a position in IRMD in Q2 2019 and has held it in 29 quarters since. The position peaked at $262K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • HM Payson & Co held 2,718 shares of iRadimed worth $260K as of Q2 2026.
  • HM Payson & Co bought 7 iRadimed shares in Q2 2026, an estimated $638.
  • iRadimed made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #407 holding.
  • HM Payson & Co first reported a position in iRadimed in Q2 2019 and has held it in 29 quarters since.
  • HM Payson & Co's iRadimed position peaked at $262K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.